Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

News

American Renal Associates Receives an SEC Subpoena; Block & Leviton LLP Encourages Shareholders to Contact the Firm

gbafNews28

BOSTON, March 30, 2019 — Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, informs investors that on March 28, 2019, American Renal Associates Holdings Inc. (“American Renal” or the “Company”) (NYSE:ARA) received a subpoena from the Securities and Exchange Commission.

Additionally, on March 28, 2019, a complaint was filed in the District of New Jersey, captioned Vandevar v. American Renal Associates Holdings Inc. et al., 2:19-cv-09074, relating to American Renal’s announcement that certain of American Renal’s annual and quarterly reports which were filed with the Securities and Exchange Commission could no longer be relied upon and would have to be restated. A judge has not yet been assigned to the case.

If you have purchased or otherwise acquired American Renal securities between August 10, 2016 and March 27, 2019, and have questions about your legal rights, or possess information relevant to this investigation, you are encouraged to contact Attorney Dan DeMaria at (888) 868-2385, by email at dan@blockesq.com, or by visiting https://shareholder.law/cases/?case=americanrenal. Additionally, those interested in serving as lead Plaintiff must apply to do so before the May 27, 2019, lead plaintiff deadline.

Block & Leviton LLP was recently ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nation’s largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.

This notice may constitute attorney advertising.

CONTACT:

BLOCK & LEVITON LLP Dan DeMaria, Esq. (617) 398-5660 phone 155 Federal Street, Suite 400 Boston, MA 02110 dan@blockesq.com

SOURCE Block & Leviton LLP

Primary Logo

Advertisement
Editorial & Advertiser disclosure

Call for Entries

Global Banking and Finance Review Awards Nominations 2022
2022 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now

Recommended

Global Banking & Finance Review® is a leading financial portal and Print Magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management. Copyright © 2010-2021 GBAF Publications Ltd - All Rights Reserved.